Bath & Body Works, Inc. (NYSE:BBWI) Given Consensus Rating of "Moderate Buy" by Brokerages

Key Points

• Bath & Body Works has received a consensus rating of "Moderate Buy" from 15 analysts, with 12 recommending a buy and 3 a hold. The average price target among brokerages is approximately $39.69.
• The company declared a quarterly dividend of $0.20 per share, yielding around 3.2%, with a dividend payout ratio of 23.74%.
• For the latest quarter, Bath & Body Works reported an EPS of $0.37, meeting analysts' expectations, but with a 0.8% decline in revenue compared to the previous year.

Bath & Body Works, Inc. (NYSE:BBWI - Get Free Report) has received a consensus rating of "Moderate Buy" from the fifteen ratings firms that are currently covering the firm, Marketbeat reports. Three research analysts have rated the stock with a hold recommendation and twelve have given a buy recommendation to the company. The average twelve-month price target among analysts that have updated their coverage on the stock in the last year is $39.6923.

Several research firms recently commented on BBWI. Telsey Advisory Group reaffirmed an "outperform" rating and issued a $38.00 price target on shares of Bath & Body Works in a report on Thursday, August 28th. JPMorgan Chase & Co. increased their price target on Bath & Body Works from $40.00 to $46.00 and gave the company an "overweight" rating in a report on Monday, July 28th. The Goldman Sachs Group cut their price target on Bath & Body Works from $44.00 to $43.00 and set a "buy" rating for the company in a report on Friday, May 30th. UBS Group cut their price target on Bath & Body Works from $36.00 to $32.00 and set a "neutral" rating for the company in a report on Friday, August 29th. Finally, Barclays increased their price objective on Bath & Body Works from $30.00 to $32.00 and gave the stock an "equal weight" rating in a research report on Friday, August 29th.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently modified their holdings of the company. T. Rowe Price Investment Management Inc. boosted its position in shares of Bath & Body Works by 7.6% during the first quarter. T. Rowe Price Investment Management Inc. now owns 11,016,767 shares of the company's stock worth $334,029,000 after buying an additional 781,681 shares during the period. JPMorgan Chase & Co. increased its holdings in Bath & Body Works by 11.5% during the 2nd quarter. JPMorgan Chase & Co. now owns 7,080,106 shares of the company's stock worth $212,120,000 after purchasing an additional 733,000 shares during the period. Victory Capital Management Inc. increased its holdings in Bath & Body Works by 14,732.0% during the 1st quarter. Victory Capital Management Inc. now owns 6,798,108 shares of the company's stock worth $206,119,000 after purchasing an additional 6,752,274 shares during the period. Alliancebernstein L.P. increased its holdings in Bath & Body Works by 5.8% during the 2nd quarter. Alliancebernstein L.P. now owns 5,737,796 shares of the company's stock worth $171,904,000 after purchasing an additional 315,738 shares during the period. Finally, Cooper Creek Partners Management LLC increased its holdings in Bath & Body Works by 42.7% during the 2nd quarter. Cooper Creek Partners Management LLC now owns 5,409,919 shares of the company's stock worth $162,081,000 after purchasing an additional 1,619,276 shares during the period. 95.14% of the stock is currently owned by hedge funds and other institutional investors.

Bath & Body Works Stock Down 4.5%

Shares of BBWI stock traded down $1.18 on Friday, hitting $25.11. The company had a trading volume of 10,541,740 shares, compared to its average volume of 7,282,604. The firm has a market cap of $5.18 billion, a P/E ratio of 7.45, a price-to-earnings-growth ratio of 0.86 and a beta of 1.49. Bath & Body Works has a twelve month low of $24.93 and a twelve month high of $41.87. The company has a 50-day moving average price of $29.58 and a 200-day moving average price of $29.77.

Bath & Body Works (NYSE:BBWI - Get Free Report) last released its quarterly earnings results on Thursday, August 28th. The company reported $0.37 earnings per share for the quarter, hitting analysts' consensus estimates of $0.37. Bath & Body Works had a negative return on equity of 48.43% and a net margin of 9.88%.The company had revenue of $1.55 billion during the quarter, compared to analysts' expectations of $1.55 billion. During the same quarter in the prior year, the firm posted $0.37 EPS. Bath & Body Works's quarterly revenue was down .8% compared to the same quarter last year. Bath & Body Works has set its Q3 2025 guidance at 0.370-0.45 EPS. FY 2025 guidance at 3.350-3.600 EPS. Equities research analysts expect that Bath & Body Works will post 3.3 EPS for the current year.

Bath & Body Works Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, September 5th. Stockholders of record on Friday, August 22nd were given a dividend of $0.20 per share. This represents a $0.80 annualized dividend and a dividend yield of 3.2%. The ex-dividend date was Friday, August 22nd. Bath & Body Works's dividend payout ratio (DPR) is currently 23.74%.

About Bath & Body Works

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.